Jiangsu Deli Biotech Co., Ltd.

Jiangsu Deli Biotech Co., Ltd. was established in 1992. The company's core business is the R&D, production, and sales of biopharmaceuticals and generic chemical drugs, with a strategic focus on innovative long-acting biologics, and an annual production capacity of 50 million vials. In April 2020, it was successfully listed on the National Equities Exchange and Quotations (NEEQ) with stock code 873430.  The company has established the corporate mission of "Medicine makes life better", the corporate philosophy of "Confidence, Integrity, Public Service," and the corporate values of "Innovation, Unity, Dedication, Honesty."